Search

Charalabos Te Pothoulakis

from Chestnut Hill, MA
Age ~73
Get Report
Also known as:
Charalabos T Pothoulakis, Harry P Pothoulakis, Ch Pothoulakis, Charalabos Pothoulakis Dr, S S, Harry S
Related to:
Margarita H Pothoulakis, 67Antonios Pothoulakis, 34Georgios Pothoulakis, 36Pothoulaki Margaritah
Connected to:
Shasheen Pothula, 32Joseph PotichaDana S Potier, 47Florence N Potier, 97Lisa Potier, 61David L Potigian, 55Frank PotkaiJill E Potkay, 43Adithya Potluri, 33Chakradhar Potluri, 52

Charalabos Pothoulakis Phones & Addresses

  • Chestnut Hill, MA
  • 920 S Gretna Green Way, Los Angeles, CA 90049 (424) 832-3089
  • 10833 Le Conte Ave, Los Angeles, CA 90095
  • 22 Allen Ave, Waban, MA 02468 (617) 527-0328
  • Baltimore, MD
  • Watertown, MA

Publications

Us Patents

Methods Of Treating Inflammatory Bowel Disease

View page
US Patent:
20060088533, Apr 27, 2006
Filed:
Oct 7, 2005
Appl. No.:
11/245610
Inventors:
Charalabos Pothoulakis - Waban MA, US
J. LaMont - West Newton MA, US
International Classification:
A61K 39/395
A61K 38/18
US Classification:
424145100, 514002000
Abstract:
Methods for treating intestinal inflammation by inhibiting toxin B-mediated activation of the epidermal growth factor receptor or by inhibiting toxin B-mediated activation of the extracellular signal-regulated kinase 1/2 are described.

Use Of Antagonists Of Ghrelin Or Ghrelin Receptor To Treat Intestinal Inflammation

View page
US Patent:
20070025991, Feb 1, 2007
Filed:
Mar 19, 2004
Appl. No.:
10/549688
Inventors:
Charalabos Pothoulakis - Waban MA, US
Christos Mantzoros - Watertown MA, US
Dezheng Zhao - Newton MA, US
International Classification:
A61K 39/395
A61K 38/17
A61K 38/22
US Classification:
424145100, 514012000
Abstract:
Methods for treating intestinal inflammation or ghrelin-mediated inflammation by inhibiting the activity of ghrelin or its receptor are described. Also described are methods for identifying ghrelin antagonists and ghrelin receptor antagonists.

Methods For Treating Inflammation By Disrupting Mch-Mediated Signaling

View page
US Patent:
20080124319, May 29, 2008
Filed:
May 16, 2007
Appl. No.:
11/804013
Inventors:
Charalabos Pothoulakis - Waban MA, US
Efi Kokkotou - Boston MA, US
International Classification:
A61K 39/395
A61P 29/00
US Classification:
4241301
Abstract:
Disclosed herein are methods for treating an inflammatory condition in a patient comprising administering an agent that inhibits the signaling activity of MCH, thereby inhibiting the inflammatory response in the tissue, and in a mammal comprising administering to the mammal an effective amount of an agent that inhibits MCH activity, MCH binding to an MCH receptor or the signaling activity of an MCH receptor that mediates intestinal inflammation.

Saif, An Anti-Inflammatory Factor, And Methods Of Use Thereof

View page
US Patent:
20050032674, Feb 10, 2005
Filed:
Jul 6, 2004
Appl. No.:
10/885380
Inventors:
Ciaran Kelly - West Newton MA, US
Charalabos Pothoulakis - Waban MA, US
Stavros Sougioultzis - Brookline MA, US
Killimangalam Bhaskar - Lexington MA, US
International Classification:
A61K038/16
A61K031/715
C07K014/47
US Classification:
514008000, 514054000, 530395000, 536123120
Abstract:
The invention features a novel soluble anti-inflammatory factor (SAIF), methods of SAIF production and purification, and methods of using SAIF for the treatment or prevention of an inflammatory disease or disorder.
Control profile
Charalabos Te Pothoulakis from Chestnut Hill, MA, age ~73 Get Report